Silka

Manufacturer: Genomma Lab USA, Inc. | Sun Pharma Canada Inc.
Effective date: 2025-07-02
Label type: HUMAN OTC DRUG LABEL
Version: 7
Source: full-release
Hydrated at: 2026-06-01 01:06:24

Label at a glance#

ProductSilka Antifungal

Active ingredientTERBINAFINE HYDROCHLORIDE

Label structure11 sections

Indications and uses

cures most athlete's foot (tinea pedis) cures most jock itch (tinea cruris) and ringworm (tinea corporis) relieves itching, burning, cracking and scaling which accompany these conditions

Dosage and administration

adults and children 12 years and over use the tip of the cap to break the seal and open the tube wash the affected skin with soap and water and dry completely before applying. for athlete's foot wear well-fitting, ventilated shoes. Change shoes and socks at least once daily. between the toes only: apply twice a day (morning and night) for 1 week or as directed by a doctor. on the bottom or sides of the foot: apply...

Storage and handling

TAMPER EVIDENT: DO NOT USE IF THE SEAL ON THE TUBE IS PUNCTURED OR NOT VISIBLE store at controlled room temperature 20° to 25°C (68° to 77°F) see carton or tube crimp for lot number and expiration date

Contacts and useful links#

PhoneLabel contact1 877 994 3666

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Terbinafine hydrochloride 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

cures most athlete's foot (tinea pedis)
cures most jock itch (tinea cruris) and ringworm (tinea corporis)
relieves itching, burning, cracking and scaling which accompany these conditions

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

on nails or scalp
in or near the mouth or eyes
for vaginal yeast infections

OTC - WHEN USING SECTION

When using this productdo not get into eyes. If eye contact occurs, rinse thoroughly with water.

OTC - STOP USE SECTION

Stop use and ask a doctor iftoo much irritation occurs or gets worse.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 12 years and over
use the tip of the cap to break the seal and open the tube
wash the affected skin with soap and water and dry completely before applying.
for athlete's footwear well-fitting, ventilated shoes. Change shoes and socks at least once daily.
between the toes only:apply twice a day (morning and night) for 1 weekor as directed by a doctor.
on the bottom or sides of the foot:apply twice a day (morning and night) for 2 weeksor as directed by a doctor.
for jock itch and ringworm:apply once a day (morning ornight) for 1 weekor as directed by a doctor.
wash hands after each use.
children under 12 years: ask a doctor.

Other information

STORAGE AND HANDLING SECTION

TAMPER EVIDENT: DO NOT USE IF THE SEAL ON THE TUBE IS PUNCTURED OR NOT VISIBLE
store at controlled room temperature 20° to 25°C (68° to 77°F)
see carton or tube crimp for lot number and expiration date

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol.

Questions?

OTC - QUESTIONS SECTION

1 877 994 3666Monday to Friday, 8 am to 6 pm Central time.

SPL UNCLASSIFIED SECTION

Distributed by:
Genomma Lab USA Inc., Houston, TX, 77027

PRINCIPAL DISPLAY PANEL - 30 g Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Terbinafine Hydrochloride Cream 1% - Antifungal

SILKA ^®

ANTIFUNGAL CREAM FOR ATHLETE'S FOOT

Full prescription strength

NET WT.
1 oz (30 g)

IMAGE-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1739221	SILKA 1 % Topical Cream	PSN	7
992528	terbinafine HCl 1 % Topical Cream	PSN	7
1739221	terbinafine hydrochloride 10 MG/ML Topical Cream [Silka Cream]	SBD	7
992528	terbinafine hydrochloride 10 MG/ML Topical Cream	SCD	7
1739221	Silka 1 % Topical Cream	SY	7
1739221	Silka Cream 10 MG/ML Topical Cream	SY	7
992528	terbinafine hydrochloride 1 % Topical Cream	SY	7

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
TERBINAFINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
55a24767-1759-5f6a-8888-ea4aa0adac21	Product name	1	20140508
db9701af-cb4f-b8ba-d282-6bc5b6b7c467	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
50066-080-02	Silka Antifungal	30 g in 1 TUBE	CREAM	30	7
50066-080-02	Silka Antifungal	1 in 1 CARTON	CREAM	1	7
50066-080-03	Silka Antifungal	30 g in 1 TUBE	CREAM	30	7
50066-080-03	Silka Antifungal	1 in 1 CARTON	CREAM	1	7
50066-080-05	Silka Antifungal	15 g in 1 TUBE	CREAM	15	7
50066-080-05	Silka Antifungal	1 in 1 CARTON	CREAM	1	7

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Terbinafine Hydrochloride	ACTIVE INGREDIENT	012C11ZU6G	1
Terbinafine	ACTIVE MOIETY	G7RIW8S0XP	1
benzyl alcohol	INACTIVE INGREDIENT	LKG8494WBH	1
cetyl alcohol	INACTIVE INGREDIENT	936JST6JCN	1
cetyl palmitate	INACTIVE INGREDIENT	5ZA2S6B08X	1
isopropyl myristate	INACTIVE INGREDIENT	0RE8K4LNJS	1
polysorbate 60	INACTIVE INGREDIENT	CAL22UVI4M	1
sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	1
sorbitan monostearate	INACTIVE INGREDIENT	NVZ4I0H58X	1
stearyl alcohol	INACTIVE INGREDIENT	2KR89I4H1Y	1
water	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

Silka Antifungal
Terbinafine Hydrochloride
BENZYL ALCOHOL
CETYL ALCOHOL
CETYL PALMITATE
ISOPROPYL MYRISTATE
POLYSORBATE 60
WATER
SODIUM HYDROXIDE
SORBITAN MONOSTEARATE
STEARYL ALCOHOL
TERBINAFINE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
50066-080	50066-080-02, 50066-080-03, 50066-080-05

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
BENZYL ALCOHOL	LKG8494WBH	IACT
CETYL ALCOHOL	936JST6JCN	IACT
CETYL PALMITATE	5ZA2S6B08X	IACT
ISOPROPYL MYRISTATE	0RE8K4LNJS	IACT
POLYSORBATE 60	CAL22UVI4M	IACT
WATER	059QF0KO0R	IACT
SODIUM HYDROXIDE	55X04QC32I	IACT
SORBITAN MONOSTEARATE	NVZ4I0H58X	IACT
STEARYL ALCOHOL	2KR89I4H1Y	IACT
TERBINAFINE HYDROCHLORIDE	012C11ZU6G	ACTIM

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 32 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
cetyl alcohol	CETYL ALCOHOL	936JST6JCN	CREAM / TOPICAL		1280 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	CREAM / TOPICAL		69 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	CREAM / TOPICAL		69 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
polysorbate 60	POLYSORBATE 60	CAL22UVI4M	CREAM / TOPICAL		225 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
stearyl alcohol	STEARYL ALCOHOL	2KR89I4H1Y	CREAM / TOPICAL		162000 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
sorbitan monostearate	SORBITAN MONOSTEARATE	NVZ4I0H58X	CREAM / TOPICAL		177 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
polysorbate 60	POLYSORBATE 60	CAL22UVI4M	CREAM / TOPICAL		225 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
sorbitan monostearate	SORBITAN MONOSTEARATE	NVZ4I0H58X	CREAM / TOPICAL		177 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
cetyl alcohol	CETYL ALCOHOL	936JST6JCN	CREAM / TOPICAL		1280 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
sorbitan monostearate	SORBITAN MONOSTEARATE	NVZ4I0H58X	CREAM / TOPICAL		177 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
isopropyl myristate	ISOPROPYL MYRISTATE	0RE8K4LNJS	CREAM / TOPICAL		65000 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
cetyl palmitate	CETYL PALMITATE	5ZA2S6B08X	CREAM / TOPICAL	0.32 %w/w		Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
benzyl alcohol	BENZYL ALCOHOL	LKG8494WBH	CREAM / TOPICAL		160 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
cetyl palmitate	CETYL PALMITATE	5ZA2S6B08X	CREAM / TOPICAL	0.32 %w/w		Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
benzyl alcohol	BENZYL ALCOHOL	LKG8494WBH	CREAM / TOPICAL		160 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
cetyl alcohol	CETYL ALCOHOL	936JST6JCN	CREAM / TOPICAL		1280 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
benzyl alcohol	BENZYL ALCOHOL	LKG8494WBH	CREAM / TOPICAL		160 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
isopropyl myristate	ISOPROPYL MYRISTATE	0RE8K4LNJS	CREAM / TOPICAL		65000 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
polysorbate 60	POLYSORBATE 60	CAL22UVI4M	CREAM / TOPICAL		225 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	CREAM / TOPICAL		69 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
benzyl alcohol	BENZYL ALCOHOL	LKG8494WBH	CREAM / TOPICAL		160 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
isopropyl myristate	ISOPROPYL MYRISTATE	0RE8K4LNJS	CREAM / TOPICAL		65000 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	CREAM / TOPICAL		69 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
cetyl palmitate	CETYL PALMITATE	5ZA2S6B08X	CREAM / TOPICAL	0.32 %w/w		Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
isopropyl myristate	ISOPROPYL MYRISTATE	0RE8K4LNJS	CREAM / TOPICAL		65000 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
sorbitan monostearate	SORBITAN MONOSTEARATE	NVZ4I0H58X	CREAM / TOPICAL		177 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
stearyl alcohol	STEARYL ALCOHOL	2KR89I4H1Y	CREAM / TOPICAL		162000 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
stearyl alcohol	STEARYL ALCOHOL	2KR89I4H1Y	CREAM / TOPICAL		162000 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
cetyl alcohol	CETYL ALCOHOL	936JST6JCN	CREAM / TOPICAL		1280 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
polysorbate 60	POLYSORBATE 60	CAL22UVI4M	CREAM / TOPICAL		225 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
stearyl alcohol	STEARYL ALCOHOL	2KR89I4H1Y	CREAM / TOPICAL		162000 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
cetyl palmitate	CETYL PALMITATE	5ZA2S6B08X	CREAM / TOPICAL	0.32 %w/w		Exact identifier — unii+route+dosage form 4 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077511-001	TERBINAFINE HYDROCHLORIDE	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL			2007-07-02

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A077511-001	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL	2007-07-02	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Silka Antifungal	TERBINAFINE HYDROCHLORIDE	Genomma Lab USA, Inc.	a32cf699-e63e-4bd3-a5af-9e1ba447e02e	2025-07-02	Warnings	Exact identifier ndc (package): 50066-080-03 ndc (package): 50066-080-05 ndc (package): 50066-080-02 ndc (product): 50066-080 ndc11 (package): 50066008002 ndc11 (package): 50066008003 ndc11 (package): 50066008005 spl id: 38f62b9e-4081-44e8-e063-6394a90a1f3a spl set id: a32cf699-e63e-4bd3-a5af-9e1ba447e02e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.